Home/Filings/4/0001104659-23-093601
4//SEC Filing

Heier Jeffrey S. 4

Accession 0001104659-23-093601

CIK 0001393434other

Filed

Aug 17, 8:00 PM ET

Accepted

Aug 18, 8:45 PM ET

Size

5.6 KB

Accession

0001104659-23-093601

Insider Transaction Report

Form 4
Period: 2023-08-02
Heier Jeffrey S.
Chief Scientific Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-08-02+17,35017,350 total
    Exercise: $4.30Exp: 2033-08-01Common Stock (17,350 underlying)
Footnotes (1)
  • [F1]Subject to the reporting person's continued service as a consultant to the Company, the option will vest over one year, with 1/12 of the shares underlying the option vesting monthly beginning on the one-month anniversary of the Vesting Commencement Date. The Vesting Commencement Date for this award is July 1, 2023.

Issuer

OCULAR THERAPEUTIX, INC

CIK 0001393434

Entity typeother

Related Parties

1
  • filerCIK 0001653082

Filing Metadata

Form type
4
Filed
Aug 17, 8:00 PM ET
Accepted
Aug 18, 8:45 PM ET
Size
5.6 KB